FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313650054> ?p ?o ?g. }

• W4313650054 abstract "Heart failure (HF) is a critical complication in elderly patients with atrial fibrillation (AF) and diabetes mellitus (DM). Recent preclinical studies suggested that non-vitamin K antagonist oral anticoagulants (NOACs) can potentially suppress the progression of cardiac fibrosis and ischemic cardiomyopathy. Whether different oral anticoagulants influence the risk of HF in older adults with AF and DM is unknown. This study aimed to evaluate the risk of HF in elderly patients with AF and DM who were administered NOACs or warfarin.A nationwide retrospective cohort study was conducted based on claims data from the entire Taiwanese population. Target trial emulation design was applied to strengthen causal inference using observational data. Patients aged ≥ 65 years with AF and DM on NOAC or warfarin treatment between 2012 and 2019 were included and followed up until 2020. The primary outcome was newly diagnosed HF. Propensity score-based fine stratification weightings were used to balance patient characteristics between NOAC and warfarin groups. Hazard ratios (HRs) were estimated using Cox proportional hazard models.The study included a total of 24,835 individuals (19,710 NOAC and 5,125 warfarin users). Patients taking NOACs had a significantly lower risk of HF than those taking warfarin (HR = 0.80, 95% CI 0.74-0.86, p < 0.001). Subgroup analyses for individual NOACs suggested that dabigatran (HR = 0.86, 95% CI 0.80-0.93, p < 0.001), rivaroxaban (HR = 0.80, 95% CI 0.74-0.86, p < 0.001), apixaban (HR = 0.78, 95% CI 0.68-0.90, p < 0.001), and edoxaban (HR = 0.72, 95% CI 0.60-0.86, p < 0.001) were associated with lower risks of HF than warfarin. The findings were consistent regardless of age and sex subgroups and were more prominent in those with high medication possession ratios. Several sensitivity analyses further supported the robustness of our findings.This nationwide cohort study demonstrated that elderly patients with AF and DM taking NOACs had a lower risk of incident HF than those taking warfarin. Our findings suggested that NOACs may be the preferred oral anticoagulant treatment when considering the prevention of heart failure in this vulnerable population. Future research is warranted to elucidate causation and investigate the underlying mechanisms." @default.
• W4313650054 created "2023-01-07" @default.
• W4313650054 creator A5009114082 @default.
• W4313650054 creator A5017216927 @default.
• W4313650054 creator A5034098370 @default.
• W4313650054 creator A5037135870 @default.
• W4313650054 creator A5043051823 @default.
• W4313650054 creator A5046530211 @default.
• W4313650054 creator A5049141087 @default.
• W4313650054 creator A5055363053 @default.
• W4313650054 creator A5081716310 @default.
• W4313650054 creator A5082543307 @default.
• W4313650054 date "2023-01-06" @default.
• W4313650054 modified "2023-10-09" @default.
• W4313650054 title "Risk of heart failure in elderly patients with atrial fibrillation and diabetes taking different oral anticoagulants: a nationwide cohort study" @default.
• W4313650054 cites W1519320417 @default.
• W4313650054 cites W1900651926 @default.
• W4313650054 cites W1981285115 @default.
• W4313650054 cites W2000445173 @default.
• W4313650054 cites W2036193982 @default.
• W4313650054 cites W2046496330 @default.
• W4313650054 cites W2063844762 @default.
• W4313650054 cites W2072203364 @default.
• W4313650054 cites W2086431863 @default.
• W4313650054 cites W2106960442 @default.
• W4313650054 cites W2111412070 @default.
• W4313650054 cites W2111635289 @default.
• W4313650054 cites W2114437291 @default.
• W4313650054 cites W2143847103 @default.
• W4313650054 cites W2147018083 @default.
• W4313650054 cites W2162586165 @default.
• W4313650054 cites W2219147369 @default.
• W4313650054 cites W2251007344 @default.
• W4313650054 cites W2264767503 @default.
• W4313650054 cites W2366275743 @default.
• W4313650054 cites W2529136798 @default.
• W4313650054 cites W2546446487 @default.
• W4313650054 cites W2598303606 @default.
• W4313650054 cites W2604459030 @default.
• W4313650054 cites W2610602137 @default.
• W4313650054 cites W2774630531 @default.
• W4313650054 cites W2790222610 @default.
• W4313650054 cites W2898763654 @default.
• W4313650054 cites W2907331886 @default.
• W4313650054 cites W2917172139 @default.
• W4313650054 cites W2921702202 @default.
• W4313650054 cites W2922145910 @default.
• W4313650054 cites W2934504605 @default.
• W4313650054 cites W2943005888 @default.
• W4313650054 cites W2968633786 @default.
• W4313650054 cites W2978317289 @default.
• W4313650054 cites W2982188023 @default.
• W4313650054 cites W3029787982 @default.
• W4313650054 cites W3034331236 @default.
• W4313650054 cites W3082188176 @default.
• W4313650054 cites W3083490100 @default.
• W4313650054 cites W3094749662 @default.
• W4313650054 cites W3136124773 @default.
• W4313650054 cites W3167159522 @default.
• W4313650054 cites W3174019935 @default.
• W4313650054 cites W3202672160 @default.
• W4313650054 cites W4212917065 @default.
• W4313650054 doi "https://doi.org/10.1186/s12933-022-01688-1" @default.
• W4313650054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36609317" @default.
• W4313650054 hasPublicationYear "2023" @default.
• W4313650054 type Work @default.
• W4313650054 citedByCount "5" @default.
• W4313650054 countsByYear W43136500542023 @default.
• W4313650054 crossrefType "journal-article" @default.
• W4313650054 hasAuthorship W4313650054A5009114082 @default.
• W4313650054 hasAuthorship W4313650054A5017216927 @default.
• W4313650054 hasAuthorship W4313650054A5034098370 @default.
• W4313650054 hasAuthorship W4313650054A5037135870 @default.
• W4313650054 hasAuthorship W4313650054A5043051823 @default.
• W4313650054 hasAuthorship W4313650054A5046530211 @default.
• W4313650054 hasAuthorship W4313650054A5049141087 @default.
• W4313650054 hasAuthorship W4313650054A5055363053 @default.
• W4313650054 hasAuthorship W4313650054A5081716310 @default.
• W4313650054 hasAuthorship W4313650054A5082543307 @default.
• W4313650054 hasBestOaLocation W43136500541 @default.
• W4313650054 hasConcept C126322002 @default.
• W4313650054 hasConcept C164705383 @default.
• W4313650054 hasConcept C207103383 @default.
• W4313650054 hasConcept C2776301958 @default.
• W4313650054 hasConcept C2776704044 @default.
• W4313650054 hasConcept C2778198053 @default.
• W4313650054 hasConcept C2778661090 @default.
• W4313650054 hasConcept C2778810321 @default.
• W4313650054 hasConcept C2779161974 @default.
• W4313650054 hasConcept C2780638905 @default.
• W4313650054 hasConcept C2908647359 @default.
• W4313650054 hasConcept C44249647 @default.
• W4313650054 hasConcept C50382708 @default.
• W4313650054 hasConcept C71924100 @default.
• W4313650054 hasConcept C99454951 @default.
• W4313650054 hasConceptScore W4313650054C126322002 @default.
• W4313650054 hasConceptScore W4313650054C164705383 @default.
• W4313650054 hasConceptScore W4313650054C207103383 @default.
• W4313650054 hasConceptScore W4313650054C2776301958 @default.
• W4313650054 hasConceptScore W4313650054C2776704044 @default.

• next